Korean stock Bridge Biotherapeutics surged over 20% today, with a market value reaching around $36 million.

BlockBeats News, June 20th, the South Korean listed biotechnology company Bridge Biotherapeutics, Inc. saw its stock price rise by 20.59% today, bringing its market capitalization to 49.218 billion Korean won, approximately 36 million US dollars.

Prior to this, investment company Parataxis Holdings, which had previously focused on the digital asset sector, announced that it had signed a definitive agreement with the biotechnology company Bridge Biotherapeutics, Inc. to invest 25 billion Korean won to acquire a controlling stake in the company (the "Transaction"). Upon completion of the transaction, the company plans to change its corporate name to Parataxis Korea and continue its listing on KOSDAQ.